Therefore, the immunotherapeutic strategies of sepsis in the past were mainly to inhibit the inflammatory response and block the pro-inflammatory cytokines such as PAMPs, Toll-like cytokines (TLRs), TNF-α, IL-6, etc., but the results were not as expected. The gene discussed is TNF; the disease is Sepsis.